O Czech, S Rutkowski, A Kowaluk, P Kiper… - Frontiers in Public …, 2023 - frontiersin.org
Background Appropriately selected complementary therapies, such as virtual reality (VR) and active video games (AVG), provide support to young patients during the process of …
A lack of relevant genetic models and cell lines hampers our understanding of hepatoblastoma pathogenesis and the development of new therapies for this neoplasm …
AR Marley, A Domingues, T Ghosh… - JNCI cancer …, 2022 - academic.oup.com
Background Pediatric cancer incidence has steadily increased concurrent with rising adult obesity, but associations between maternal obesity and associated comorbidities and …
Objective Hepatoblastoma (HB) is the most common pediatric primary malignant liver tumor, its incidence has been increasing worldwide, but recent changes in incidence and outcomes …
Most children with tumors will require one or more surgical interventions as part of the care and treatment, including making a diagnosis, obtaining adequate venous access …
E Hiyama, T Hishiki, K Watanabe, K Ida… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE We report here the outcomes and late effects of the Japanese Study Group for Pediatric Liver Tumors (JPLT)-2 protocol, on the basis of cisplatin-tetrahydropyranyl …
Hepatoblastoma (HB) is the most common pediatric liver malignancy. High-risk patients have poor survival, and current chemotherapies are associated with significant toxicities …
P Sumazin, TL Peters, SF Sarabia, HR Kim… - Journal of …, 2022 - Elsevier
Background & Aims Hepatoblastoma (HB) and hepatocellular carcinoma (HCC) are the predominant liver cancers in children, though their respective treatment options and …
J Hager, CM Sergi - Exon Publications, 2021 - exonpublications.com
Hepatoblastoma is the most common liver cancer in children aged 3 years and younger. The differential diagnosis of this neoplasm is crucial for the proper management. Recent …